Florida Attorney General Sues Pfizer for 'Misleading' COVID-19 Vaccine Safety Claims

{
  "signal_id": "8bad3511-266c-d7c4-46d5-6f59192f694f",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-10-05T18:55:52+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "url": "https://www.benzinga.com/news/health-care/26/10/62174268/florida-attorney-general-sues-pfizer-for-misleading-covid-19-vaccine-safety-claims",
    "title": "Florida Attorney General Sues Pfizer for 'Misleading' COVID-19 Vaccine Safety Claims - Benzinga",
    "excerpt": "A legal filing in Florida accuses pharmaceutical giant Pfizer Inc . (NYSE: PFE ) and Chairman and CEO Albert Bourla of deceiving consumers by concealing critical safety risks and unverified transmission claims. The lawsuit was filed by the Office of the Attorney General of the State of Florida (Department of Legal Affairs), on behalf of the State of Florida, led by Florida Attorney General James Uthmeier . It alleges that Pfizer violated the Florida Deceptive and Unfair Trade Practices Act by misleading the public, hiding internal safety data, and disparaging concerned citizens. Benzinga has reached out to Pfizer for comments and will update the story upon receiving their stance. Florida Attorney General James Uthmeier has opposed the corporate marketing and forced mandates of the COVID-19 vaccine, publicly accusing drug manufacturers of concealing serious health risks. According to the court document, Pfizer spent more than $10 billion on advertising from 2020 to 2023 to build consumer demand for its novel mRNA COVID-19 vaccine . This extensive marketing push successfully generated over $80 billion in vaccine sales for the company. During this same period, Bourla earned nearly $102 million in compensation, supplemented by stock profits and book sales. To secure these windfall profits, Pfizer executives conducted media appearances assuring Florida residents the vaccine was...",
    "product": "COVID-19 vaccine",
    "summary": "Pfizer generated over $80 billion in sales from its COVID-19 vaccine.",
    "planning": false,
    "image_url": "https://cdn.benzinga.com/cdn-cgi/image/width=1200,height=800,fit=crop/files/images/story/2026/10/05/JPMorgan-Faces-Trump-Lawsuit.jpg",
    "confidence": 0.8,
    "product_data": {
      "name": "COVID-19 vaccine",
      "full_text": "novel mRNA COVID-19 vaccine",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical"
    ],
    "published_at": "2026-10-05T18:55:52Z",
    "article_sentence": "This extensive marketing push successfully generated over $80 billion in vaccine sales for the company.",
    "amount_normalized": 80000000000
  }
}

curl https://signals.autobound.ai/v1/signals/8bad3511-266c-d7c4-46d5-6f59192f694f \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"pfizer.com","limit":20}'